DK3897595T3 - Nutraceutisk ophthalmisk sammensætning til behandlingen af retinale pathologier med en neovaskulær komponent - Google Patents

Nutraceutisk ophthalmisk sammensætning til behandlingen af retinale pathologier med en neovaskulær komponent Download PDF

Info

Publication number
DK3897595T3
DK3897595T3 DK19829158.5T DK19829158T DK3897595T3 DK 3897595 T3 DK3897595 T3 DK 3897595T3 DK 19829158 T DK19829158 T DK 19829158T DK 3897595 T3 DK3897595 T3 DK 3897595T3
Authority
DK
Denmark
Prior art keywords
nutraceutical
treatment
ophthalmic composition
retinal pathologies
neovascular
Prior art date
Application number
DK19829158.5T
Other languages
English (en)
Inventor
Céline Olmiere
Fabrice Mercier
Original Assignee
Thea Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thea Lab filed Critical Thea Lab
Application granted granted Critical
Publication of DK3897595T3 publication Critical patent/DK3897595T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16Inorganic salts, minerals or trace elements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07Retinol compounds, e.g. vitamin A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/34Copper; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK19829158.5T 2018-12-20 2019-12-19 Nutraceutisk ophthalmisk sammensætning til behandlingen af retinale pathologier med en neovaskulær komponent DK3897595T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18306772 2018-12-20
PCT/EP2019/086174 WO2020127641A1 (fr) 2018-12-20 2019-12-19 Composition ophtalmique nutraceutique pour le traitement de pathologies retiniennes a composante neovasculaire

Publications (1)

Publication Number Publication Date
DK3897595T3 true DK3897595T3 (da) 2023-03-27

Family

ID=65200511

Family Applications (1)

Application Number Title Priority Date Filing Date
DK19829158.5T DK3897595T3 (da) 2018-12-20 2019-12-19 Nutraceutisk ophthalmisk sammensætning til behandlingen af retinale pathologier med en neovaskulær komponent

Country Status (15)

Country Link
EP (1) EP3897595B1 (da)
CA (1) CA3122227A1 (da)
DK (1) DK3897595T3 (da)
ES (1) ES2940767T3 (da)
FI (1) FI3897595T3 (da)
HR (1) HRP20230283T1 (da)
HU (1) HUE061286T2 (da)
LT (1) LT3897595T (da)
MA (1) MA54511B1 (da)
PL (1) PL3897595T3 (da)
PT (1) PT3897595T (da)
RS (1) RS64066B1 (da)
SI (1) SI3897595T1 (da)
UA (1) UA127874C2 (da)
WO (1) WO2020127641A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA52570A (fr) 2018-05-10 2021-03-17 Regeneron Pharma Formulations contenant des protéines de fusion du récepteur vegf à haute concentration

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3034018B1 (fr) 2015-03-25 2017-11-03 Thea Lab Composition ophtalmique nutraceutique pour la sante oculaire

Also Published As

Publication number Publication date
CA3122227A1 (fr) 2020-06-25
PT3897595T (pt) 2023-03-22
EP3897595B1 (fr) 2023-03-15
FI3897595T3 (en) 2023-03-31
ES2940767T3 (es) 2023-05-11
LT3897595T (lt) 2023-04-25
UA127874C2 (uk) 2024-01-31
EP3897595A1 (fr) 2021-10-27
PL3897595T3 (pl) 2023-05-08
SI3897595T1 (sl) 2023-04-28
WO2020127641A1 (fr) 2020-06-25
RS64066B1 (sr) 2023-04-28
HRP20230283T1 (hr) 2023-05-12
HUE061286T2 (hu) 2023-06-28
MA54511B1 (fr) 2023-04-28
MA54511A (fr) 2022-03-30

Similar Documents

Publication Publication Date Title
DK3570844T3 (da) Azolopyrimidin til behandlingen af kræftrelaterede lidelser
DK3668509T3 (da) Fremgangsmåde til behandling af amyotrofisk lateralsklerose med pridopidin
DK3402499T3 (da) Sammensætninger og fremgangsmåder til behandlingen af type 1 diabetes
DK3426219T3 (da) Terapeutisk øjenbehandling med gasser
DK3615057T3 (da) Doseringsskema til behandling af kognitive svækkelser med blodplasmaprodukter
DK3681500T3 (da) Anvendelse af pilocarpinhydrochlorid til behandling af presbyopi
DK3288577T3 (da) Adiponectin-peptidomimetika til behandling af øjenlidelser
DK3481846T3 (da) 11-substituerede 24-hydroxysteroler til anvendelse til behandling af nmda-relaterede tilstande
DK3240538T3 (da) Anvendelse af masitinib til behandling af en underpopulation af patienter med amyotrofisk lateralsklerose
DK3882250T3 (da) Tetrahydropyranyl-amino-pyrrolopyrimidinon til anvendelse i behandling af btk-medierede forstyrrelser
DK3390390T3 (da) Bipyrazolylderivater egnede til behandling af autoimmunsygdomme
HK1256721A1 (zh) 用於治療眼部病症的化合物和組合物
DK3612208T5 (da) Coversin til behandlingen af autoimmune sygdomme med blisterdannelse
DK3439661T3 (da) Fremgangsmåder til behandling af øjenlidelser
DK3192524T3 (da) Hgf præparat egnet til behandling af neurologiske lidelser
DK3478713T3 (da) Sammensætninger til behandling af amyloidose
DK3432895T3 (da) Blodpladepelletlysat til anvendelse til behandling af neurologiske forstyrrelser
GB201612165D0 (en) Combinations for the treatment of type 2 diabetes
DK3724173T3 (da) Forbindelser til behandling af neuromuskulære lidelser
DK3209295T3 (da) Fremgangsmåder til behandling af øjenlidelser
DK3484475T3 (da) 1-methylnicotinamid til behandlingen af kardiovaskulær sygdom
MA41202A (fr) Copolymères polydiallymine réticulé pour le traitement du diabète de type 2
DK3886858T3 (da) Forbindelser til behandling af øjensygdomme forbundet med for megen vaskularisering
DK3574912T3 (da) Sammensætning til behandling af diabetisk sygdom
DK3096775T3 (da) SOCS-mimetika til behandling af sygdomme